Eli Lilly starts human study of potential COVID-19 treatment
Jun 01, 2020 - Nasdaq
June 1 (Reuters) - Eli Lilly and Co LLY.N said on Monday patients have been dosed to test its potential antibody treatment designed to fight COVID-19, caused by the new coronavirus. The study will assess safety and tolerability in patients hospitalized with COVID-19 and results are anticipated by the end of June, the company said in a statement. (Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli) (( ankur.banerjee@thomsonreuters.com ;; within U.S. +1 646 223 8780, outside ...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
